OTCMKTS:ARSSF Assura (ARSSF) Stock Price, News & Analysis $0.68 0.00 (0.00%) As of 09/15/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort InterestBuy This Stock About Assura Stock (OTCMKTS:ARSSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Assura alerts:Sign Up Key Stats Today's Range$0.68▼$0.6850-Day Range$0.63▼$0.6952-Week Range$0.43▼$0.72VolumeN/AAverage Volume9,153 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Assura PLC, trading as ARSSF on the OTC Markets, is a real estate investment trust specializing in primary healthcare facilities in the United Kingdom. The company acquires, develops and manages medical centres that are laid out for general practitioner (GP) practices, community health services and outpatient care. Assura structures long-term lease agreements with National Health Service (NHS) organisations and GP consortia, offering tailored financing and design solutions to meet evolving needs in primary care delivery. Since its establishment in 2003, Assura has built a diversified portfolio of primary care assets across England and Scotland. The company’s projects range from new-build developments to portfolio acquisitions and refurbishments of existing practices. By focusing exclusively on primary healthcare real estate, Assura aims to deliver stable, inflation-linked rental income while supporting health service providers in securing modern, fit-for-purpose premises. Headquartered in Altrincham, Cheshire, Assura is listed on the London Stock Exchange and abides by the regulatory framework governing UK real estate investment trusts. The company is managed by an experienced leadership team and overseen by an independent board of directors. Assura continues to pursue selective development and acquisition opportunities that align with its core strategy of partnering with NHS stakeholders and GP groups to enhance patient care infrastructure.AI Generated. May Contain Errors. Read More Receive ARSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Assura and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARSSF Stock News HeadlinesPrimary Health Properties offer to Assura shareholders closesSeptember 11, 2025 | lse.co.ukAssura seeks to delist from JSE and LSE after PHP takeoverSeptember 5, 2025 | lse.co.ukNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.September 16 at 2:00 AM | Brownstone Research (Ad)UK CMA launches phase 1 investigation of acquisition of Assura by PHPSeptember 3, 2025 | lse.co.ukUK competition watchdog to probe PHP's $2.4 billion takeover of AssuraSeptember 3, 2025 | reuters.comPrimary Health’s $2.40 Billion Assura Takeover Gets U.K. Regulatory ProbeSeptember 3, 2025 | msn.comEd Smith resigns as Assura Chair amid PHP takeoverAugust 19, 2025 | investing.comAssura Nonexecutive Chair Ed Smith ResignsAugust 19, 2025 | marketwatch.comSee More Headlines ARSSF Stock Analysis - Frequently Asked Questions How have ARSSF shares performed this year? Assura's stock was trading at $0.4910 at the beginning of 2025. Since then, ARSSF shares have increased by 38.1% and is now trading at $0.6780. How do I buy shares of Assura? Shares of ARSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/16/2025Next Earnings (Estimated)11/12/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorReal Estate Industry REIT - Healthcare Facilities Sub-IndustryN/A Current SymbolOTCMKTS:ARSSF CIKN/A Webwww.assuraplc.com Phone44-1925-420660FaxN/AEmployees86Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:ARSSF) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assura Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Assura With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.